Searched for
NEKSIUM
Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20%Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...- Cipla, Pfizer ink partnership for exclusive marketing of four brands in IndiaPfizer India and Cipla Limited have announced a strategic partnership where Cipla will exclusively market and distribute four of Pfizer's k...
- Add Pfizer, target price Rs 3,400: Centrum BrokingManagement is hopeful of achieving in-line or slightly better growth rate than the market.
- Pfizer drops 3% on valuation concernsBrokerage Centrum Broking has downgraded the stock to hold from buy with a target price of Rs 3,100.
- Buy Pfizer, target Rs 2900: Centrum BrokingBuy Pfizer Ltd. at a price target of Rs 2900.
- 10 stocks that saw target price revision, re-rating post Q2 nosBrokerage Sharekhan said Sensex companies posted 8.1 per cent year-on-year profit growth.
- Pfizer surges 7% on acquisition of Neksium brand from AstraZenecaFollowing the announcement, the scrip rose 7.15 pr cent to hit a high of Rs 1,785.80 on BSE.
- Top stocks in focus on Thursday, 1 June 2017ICRA has cut the creditworthiness of state-owned Oriental Bank of Commerce
- Pfizer acquires AstraZeneca's Neksium for Rs 75 croreNeksium was launched in India in the year 2006 and has developed strong equity with prescribers as a leading, high quality product in the A...
Load More
